Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHR vs CLDT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CLDT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

CLDT Overall Winner 6-Pillar Tally: BHR 2 – 4 CLDT Matrix Metrics: BHR 2 – 8 CLDT

As of Nov 20, 2026, Chatham Lodging Trust (CLDT) is the stronger overall head-to-head candidate over Braemar Hotels & Resorts Inc. (BHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BHR carries a Unified Composite Score of 36.1/100 (SELL) at $1.42 (20.6x Forward P/E, 4.6% operating margin), whereas CLDT carries 46.5/100 (HOLD) at $15.36 (N/M Forward P/E, 11.2% operating margin).

  • Technical & Structure Timing Caution: BHR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile CLDT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 52.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHR vs CLDT
BHR NYSE
Braemar Hotels & Resorts Inc. Common Stock
Real Estate Investment Trusts
$1.42
-5.96% 1D
Market Cap $110.9M
TTM Revenue $647M
Forward P/E 20.6x
Beta / 30D Vol 0.50β · 63% Vol
Unified Composite Score
36.1 / 100 SELL
Tech 15.0 Fund 40.0 Flow 56.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.8%), weak momentum, RSI 41
RSI-14: 41.3 · SMA20: $1.51 · SMA50: $1.55
CLDT NYSE Head-to-Head Winner
Chatham Lodging Trust
Real Estate Investment Trusts
$15.36
-0.84% 1D
Market Cap $758.5M
TTM Revenue $155M
Forward P/E N/M
Beta / 30D Vol 0.32β · 26% Vol
Unified Composite Score
46.5 / 100 HOLD
Tech 38.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 53
RSI-14: 52.7 · SMA20: $15.48 · SMA50: $14.33

6-Pillar Scorecard Institutional Category Breakdown (BHR 2 – 4 CLDT)

Columns: Metric · BHR · CLDT
1. Valuation Multiples BHR
Forward P/E 20.6x N/M
Trailing P/E 20.6x 96.8x
PEG Ratio N/M 2.28x
EV / Revenue 0.2x 4.9x
2. Growth & Scale CLDT
Revenue Growth (YoY) -29.2% +16.0%
Earnings Growth (YoY) +7.1% +266.7%
TTM Revenue (USD) $647M $155M
Market Cap $110.9M $758.5M
3. Profitability & Quality CLDT
Gross Margin 27.4% 49.4%
Operating Margin 4.6% 11.2%
Net Profit Margin -37.4% 5.0%
Return on Equity (ROE) -62.0% 2.1%
4. Balance Sheet & Cash Flow CLDT
Cash Generation (TTM) $45M $48M EBITDA
Cash Flow Margin 7.0% 30.7% EBITDA Mgn
Net Cash / Leverage -62.0% ROE $15.52 Book/Sh · 2.1% ROE
Dividend Yield 3.25% 2.45%
5. Options & Positioning BHR
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 12.5% (50th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat CLDT
OpEx & R&D Intensity 22.8% of Rev ($148M) 38.2% of Rev ($59M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Hotel & Motel Operator REIT - Hotel & Motel Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHR (2) vs CLDT (8)
Institutional Metric BHR CLDT Criterion Row Edge
Market Capitalization
Scale
$110.9M $758.5M Larger Scale CLDT
Trailing P/E Ratio
Valuation
20.6x 96.8x Lower Multiple BHR
Forward P/E Ratio
Valuation
20.6x N/M Lower Multiple BHR
Revenue Growth (YoY)
Growth
-29.2% +16.0% Higher Growth CLDT
Operating Margin (TTM)
Profitability
4.6% 11.2% Higher Margin CLDT
Net Profit Margin
Profitability
-37.4% 5.0% Higher Margin CLDT
Return on Equity (ROE)
Capital Efficiency
-62.0% 2.1% Higher ROE CLDT
52-Week Range Position
Momentum
12% ($1–$3) 88% ($6–$17) Stronger Trend CLDT
Beta / 30D Volatility
Risk Regime
0.50β · 63% Vol 0.32β · 26% Vol Lower Realized Risk CLDT
Unified Institutional Score
Composite Signal
36.1 / 100 (SELL) 46.5 / 100 (HOLD) Higher Composite CLDT
Trailing 12M Revenue (USD)
Operating Scale
$647M $155M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
27.4% 49.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.2x EV/Rev 2.28x PEG · 4.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$45M (-62.0% ROE) $48M EBITDA ($15.52 Book/Sh · 2.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CLDT +8.49 pp
BHR: -0.7% · CLDT: +7.79%
3M Horizon CLDT +42.12 pp
BHR: -30.73% · CLDT: +11.39%
6M Horizon CLDT +86.52 pp
BHR: -42.97% · CLDT: +43.55%
1Y Horizon CLDT +185.95 pp
BHR: -48.55% · CLDT: +137.4%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHR vs CLDT. Trailing 12-month operating profitability (BHR 4.6% vs CLDT 11.2%) and valuation multiples (BHR 20.6x vs CLDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BHR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$647M
Gross Margin27.4%
Op. Margin4.6%
ROE / Fwd P/E-62.0% · 20.6x
CLDT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$155M
Gross Margin49.4%
Op. Margin11.2%
ROE / Fwd P/E2.1% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 12.5%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CLDT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CLDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHR Moat Profile Cyclical / Execution-Driven Positioning
REIT - Hotel & Motel Operator
Competes within the REIT - Hotel & Motel value chain with $110.9M market capitalization and 4.6% operating margin.
OpEx & R&D Reinvestment 22.8% of Rev ($148M)
90D Engineering Disclosures 0 Published
CLDT Moat Profile Cyclical / Execution-Driven Positioning
REIT - Hotel & Motel Operator
Competes within the REIT - Hotel & Motel value chain with $758.5M market capitalization and 11.2% operating margin.
OpEx & R&D Reinvestment 38.2% of Rev ($59M)
90D Engineering Disclosures 0 Published

Investor FAQ BHR vs CLDT Key Questions & Quantitative Answers

As of Nov 20, 2026, Chatham Lodging Trust (CLDT) is the stronger overall head-to-head candidate over Braemar Hotels & Resorts Inc. (BHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BHR carries a Unified Composite Score of 36.1/100 (SELL) at $1.42 (20.6x Forward P/E, 4.6% operating margin), whereas CLDT carries 46.5/100 (HOLD) at $15.36 (N/M Forward P/E, 11.2% operating margin). Technical & Structure Timing Caution: BHR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile CLDT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 52.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CLDT leads the Growth & Scale pillar: BHR posts -29.2% YoY revenue growth and +7.1% YoY earnings growth on $647M TTM revenue (27.4% gross margin, 4.6% operating margin), compared with CLDT at +16.0% YoY revenue growth and +266.7% YoY earnings growth on $155M TTM revenue (49.4% gross margin, 11.2% operating margin). On trailing 12-month operating scale, BHR generates $647M in USD-normalized revenue versus $155M for CLDT. In operating R&D and SG&A reinvestment, BHR deploys 22.8% of Rev ($148M) (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($59M) (0 disclosures) for CLDT.

BHR screens cheaper on headline valuation multiples. BHR trades at 20.6x Forward P/E, 20.6x Trailing P/E, N/M PEG, and 0.2x EV/Revenue (7.0% FCF margin), whereas CLDT trades at N/M Forward P/E, 96.8x Trailing P/E, 2.28x PEG, and 4.9x EV/Revenue (30.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHR (-62.0% ROE) versus CLDT (2.1% ROE) capital efficiency.

In options market volatility and institutional positioning, BHR carries 12.5% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 63% Vol realized risk). By comparison, CLDT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.32β · 26% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.